BioSpace News Archive

Business

Nuevolution to Receive License Fee Payment of USD 750,000

Nuevolution today announced that Janssen Biotech has exercised its option to license one of the research programs under the multi-target collaboration entered between the parties in October 2015 - a collaboration that was expanded further in April 2016 and March 2017.

January 4, 2018
·
3 min read
Business

Pelican BioThermal Hires Dominic Hyde as New VP of Crēdo on Demand

With more than 23 years engineering expertise and leadership experience, Hyde will manage the worldwide expansion of Pelican BioThermal’s Crēdo on Demand rental program.

January 4, 2018
·
3 min read
Themis Raises EUR 10 Million in Series C Financing to Advance Clinical Pipeline

Thermis announced today the close of a Series C financing round totaling EUR 10 million.

January 4, 2018
·
4 min read
Business

BioLife Solutions Announces Preliminary 2017 Revenue Increase of 34% to $11M

BioLife today announced preliminary Q4 and full year 2017 revenue and provided additional operational updates and financial guidance for 2018.

January 4, 2018
·
4 min read
BioCapital

Bristol-Myers Jumps in on Personal Genome Diagnostics’ $75M Funding Round

PGDx is a leader in the development of tissue-based and liquid biopsy technologies and products for cancer genomics.

January 4, 2018
·
5 min read
Business

OrphoMed Appoints Gastroenterology Expert and Industry Veteran Mark Sostek, M.D. as CMO

Dr. Sostek will lead the ongoing and planned clinical trials of OrphoMed’s lead product candidate ORP-101, which is currently in a Phase 1 clinical trial for IBS-D, and the Company’s pipeline of novel dimer therapeutics.

January 4, 2018
·
2 min read
Drug Development

Audentes Announces Positive Interim Data From First Dose Cohort of ASPIRO, a Phase I/II Clinical Trial of AT132 in Patients With X-Linked Myotubular Myopathy

ASPIRO is a multicenter, multinational, open-label, ascending dose study to evaluate the safety and preliminary efficacy of AT132 in approximately 12 XLMTM patients less than five years of age.

January 4, 2018
·
11 min read
Business

Generation Bio Emerges With $25M and Former Sobi CEO as Its New Leader

Generation Bio is developing a breakthrough class of genetic medicines based on its proprietary GeneWave technology

January 4, 2018
·
5 min read
Business

AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results

Net sales for the second quarter of fiscal 2018 were $86.7 million, a decrease of 2.6%, compared to $89.0 million a year ago, primarily related to declines in the Venous Insufficiency and Core businesses, as well as declines across the majority of the Company’s Vascular Access non-BioFlo products.

January 4, 2018
·
18 min read
Business

Verastem Appoints Joseph Lobacki as Chief Commercial Officer

Mr. Lobacki, formerly Chief Commercial Officer of Medivation, will be responsible for overseeing the commercial strategy and execution for Verastem’s lead product candidate, duvelisib.

January 4, 2018
·
9 min read